A recent study has shown that metformin, a diabetes medication, may slow ageing in monkeys by preserving cognitive function and delaying tissue ageing. Conducted by Guanghui Liu's team at the Chinese Academy of Sciences,

Metformin - a drug commonly used to treat diabetes, prevents the development of long COVID, a new study published in The Lancet Infectious Diseases, University of Minnesota has found. According to the research – called COVID-OUT,

A news release from the National Institutes of Health (NIH) said that, "scientists are not clear how metformin may prevent long COVID, but they speculate the possibility of several mechanisms that reduce inflammation, decrease viral levels and suppress the formation of disease-related proteins."

A study reveals that metformin, a common diabetes medication, slows ageing in monkeys, particularly benefiting brain health

M etformin, a widely available generic drug used to treat type 2 diabetes, has recently garnered attention for its potential anti-aging effects. It has been a trusted medication s